title: GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples.
abstract: The purpose of this study was to evaluate the GenoType MTBDRsl assay (Hain Lifescience GmbH, Nehren, Germany) for its ability to detect resistance to fluoroquinolones (FLQ), injectable second-line antibiotics [kanamycin (KM) and capreomycin (CM)], and ethambutol (EMB) in Mycobacterium tuberculosis clinical strains and directly in clinical samples. A total of 34 clinical strains were characterized with the Bactec 460 TB system. Fifty-four clinical samples from 16 patients (5 were smear negative and 49 were smear positive) were also tested directly. The corresponding isolates of the clinical specimens were also analyzed with the Bactec 460TB. When there was a discrepancy between assays, pyrosequencing was performed. The overall rates of concordance of the MTBDRsl and the Bactec 460TB for the detection of FLQ, KM/CM, and EMB susceptibility in clinical strains were 72.4% (21/29), 88.8% (24/27), and 67.6% (23/34), whereas for clinical samples, rates were 86.5% (45/52), 92.3% (48/52), and 56% (28/50), respectively. In conclusion, the GenoType MTBDRsl assay may be a useful tool for making early decisions regarding KM/CM susceptibility and to a lesser extent regarding FLQ and EMB susceptibility. The test is able to detect mutations in both clinical strains and samples with a short turnaround time. However, for correct management of patients with extensively drug-resistant tuberculosis, results must be confirmed by a phenotypical method.
authors.affiliation: Servei de Microbiologiaa and Servei de Pneumologia,b Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Universitat Autònoma deBarcelona, Badalona, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Lacoma
authors.forename: N
authors.initials: N
authors.lastname: García-Sierra
authors.forename: C
authors.initials: C
authors.lastname: Prat
authors.forename: J
authors.initials: J
authors.lastname: Maldonado
authors.forename: J
authors.initials: J
authors.lastname: Ruiz-Manzano
authors.forename: L
authors.initials: L
authors.lastname: Haba
authors.forename: P
authors.initials: P
authors.lastname: Gavin
authors.forename: S
authors.initials: S
authors.lastname: Samper
authors.forename: V
authors.initials: V
authors.lastname: Ausina
authors.forename: J
authors.initials: J
authors.lastname: Domínguez
mesh_terms: D000995:Antitubercular Agents / Q000494:pharmacology*; D002207:Capreomycin / Q000494:pharmacology; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D024881:Drug Resistance, Bacterial; D004977:Ethambutol / Q000494:pharmacology*; D024841:Fluoroquinolones / Q000494:pharmacology; D005838:Genotype; D005858:Germany; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests / Q000379:methods; D025202:Molecular Diagnostic Techniques / Q000379:methods*; D020125:Mutation, Missense; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics* / Q000302:isolation & purification; D017422:Sequence Analysis, DNA; D014376:Tuberculosis / Q000382:microbiology*
chemical_list: D000995:Antitubercular Agents; D004269:DNA, Bacterial; D024841:Fluoroquinolones; D002207:Capreomycin; D007612:Kanamycin; D004977:Ethambutol
references.citation: Antimicrob Agents Chemother. 2005 Feb;49(2):571-7
references.pmid: 15673735
references.citation: J Antimicrob Chemother. 2010 Aug;65(8):1551-61
references.pmid: 20542907
references.citation: Antimicrob Agents Chemother. 2005 Aug;49(8):3192-7
references.pmid: 16048924
references.citation: Clin Infect Dis. 2011 Jun;52(11):1350-5
references.pmid: 21596676
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9869-74
references.pmid: 9275218
references.citation: J Clin Microbiol. 2011 Jul;49(7):2502-8
references.pmid: 21562102
references.citation: Antimicrob Agents Chemother. 1997 Oct;41(10):2270-3
references.pmid: 9333060
references.citation: Antimicrob Agents Chemother. 2006 Dec;50(12):4170-3
references.pmid: 17015625
references.citation: J Antimicrob Chemother. 2007 May;59(5):860-5
references.pmid: 17412727
references.citation: Antimicrob Agents Chemother. 1998 May;42(5):1295-7
references.pmid: 9593173
references.citation: J Clin Microbiol. 2011 Aug;49(8):2832-7
references.pmid: 21632897
references.citation: J Clin Microbiol. 2010 May;48(5):1683-9
references.pmid: 20335420
references.citation: Eur J Clin Microbiol Infect Dis. 2009 Jan;28(1):33-8
references.pmid: 18719956
references.citation: Mol Biotechnol. 2004 Oct;28(2):129-37
references.pmid: 15477652
references.citation: Int J Tuberc Lung Dis. 2009 Nov;13(11):1320-30
references.pmid: 19861002
references.citation: J Clin Microbiol. 2008 Nov;46(11):3660-7
references.pmid: 18784319
references.citation: Clin Microbiol Infect. 2010 Jun;16(6):607-12
references.pmid: 19673965
references.citation: J Clin Microbiol. 2009 Jun;47(6):1767-72
references.pmid: 19386845
references.citation: Antimicrob Agents Chemother. 2000 Feb;44(2):326-36
references.pmid: 10639358
references.citation: Eur Respir J. 2008 Nov;32(5):1165-74
references.pmid: 18614561
references.citation: J Clin Microbiol. 2011 Oct;49(10):3683-6
references.pmid: 21813715
references.citation: J Microbiol Methods. 2005 Jul;62(1):113-20
references.pmid: 15823399
references.citation: J Clin Microbiol. 2010 Aug;48(8):2749-53
references.pmid: 20554815
references.citation: Enferm Infecc Microbiol Clin. 2008 Jul;26 Suppl 9:33-41
references.pmid: 19195445
references.citation: Nat Med. 1997 May;3(5):567-70
references.pmid: 9142129
references.citation: Int J Tuberc Lung Dis. 2004 Sep;8(9):1157-8
references.pmid: 15455606
references.citation: Antimicrob Agents Chemother. 2006 May;50(5):1900-2
references.pmid: 16641474
references.citation: J Clin Microbiol. 2011 Jul;49(7):2557-61
references.pmid: 21562105
references.citation: Antimicrob Agents Chemother. 1994 Apr;38(4):773-80
references.pmid: 8031045
references.citation: Antimicrob Agents Chemother. 2006 Jan;50(1):104-12
references.pmid: 16377674
references.citation: J Clin Microbiol. 2009 Dec;47(12):3985-90
references.pmid: 19846642
references.citation: Expert Rev Respir Med. 2009 Oct;3(5):497-510
references.pmid: 20477339
references.citation: Clin Chim Acta. 2006 Jan;363(1-2):83-94
references.pmid: 16165119
references.citation: J Clin Microbiol. 2010 Aug;48(8):2934-9
references.pmid: 20573868
references.citation: Clin Microbiol Infect. 2005 Feb;11(2):122-30
references.pmid: 15679486
references.citation: Respir Res. 2001;2(3):164-8
references.pmid: 11686881